InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Lamothe Jeffrey G., 首席财务官. Director active across 1 company, notably Aptevo Therapeutics Inc.. Cumulatively, 10 disclosures have been logged. Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lamothe Jeffrey G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
961 股Common StockSEC:0001193125-26-343079:0
5 股Common Stock (post-reverse split May ACTIVE)SEC:0000950170-25-097267:0
3 股Common StockSEC:0000950170-25-032197:0
42 股Common StockSEC:0000950170-24-094816:0
5,500 股Common StockSEC:0000950170-24-025915:0
1,833 股Common StockSEC:0000950170-24-009003:0
11,979 股Common StockSEC:0001209191-23-045263:0
3,666 股Common StockSEC:0001209191-23-016789:0
1,834 股Common StockSEC:0001209191-23-005420:0
1,833 股Common StockSEC:0001019056-22-000112:0
10 条申报中的 10 条
About Lamothe Jeffrey G.
Lamothe Jeffrey G. is Directeur Financier and is linked to Aptevo Therapeutics Inc., where he is President and CEO. The declarant has 10 filings in total, and, across the sampled recent filings held, the period runs from 2022-02-01 to 2026-08-10; the most common transaction type is Levée d'options.
